Literature DB >> 24004141

Survival in patients with glioblastoma receiving valganciclovir.

Cecilia Söderberg-Nauclér, Afsar Rahbar, Giuseppe Stragliotto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24004141     DOI： 10.1056/NEJMc1302145

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  81 in total

1.  Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.

Authors:  Peter Baumgarten; Martin Michaelis; Florian Rothweiler; Tatjana Starzetz; Holger F Rabenau; Annemarie Berger; Lukas Jennewein; Anne K Braczynski; Kea Franz; Volker Seifert; Joachim P Steinbach; Regina Allwinn; Michel Mittelbronn; Jindrich Cinatl
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

2.  Challenging cytomegalovirus data in glioblastoma.

Authors:  Wolfgang Wick; Antje Wick; Michael Platten
Journal:  Neuro Oncol       Date:  2013-12-18       Impact factor: 12.300

3.  The legend of cytomegalovirus and glioblastoma lives on.

Authors:  Michael Weller; Riccardo Soffietti; Michael Brada
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

4.  Reply to Itzhaki and Klapper.

Authors:  Nell S Lurain; Barbara A Hanson; Jeffrey Martinson; Sue E Leurgans; Alan L Landay; David A Bennett; Julie A Schneider
Journal:  J Infect Dis       Date:  2013-11-26       Impact factor: 5.226

5.  Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients.

Authors:  Afsar Rahbar; Madeleine Cederarv; Nina Wolmer-Solberg; Charlotte Tammik; Giuseppe Stragliotto; Inti Peredo; Olesja Fornara; Xinling Xu; Mensur Dzabic; Chato Taher; Petra Skarman; Cecilia Söderberg-Nauclér
Journal:  Oncoimmunology       Date:  2015-08-24       Impact factor: 8.110

6.  Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.

Authors:  N Goerig; S Semrau; B Frey; K Korn; B Fleckenstein; K Überla; A Dörfler; F Putz; U S Gaipl; R Fietkau
Journal:  Strahlenther Onkol       Date:  2016-05-31       Impact factor: 3.621

7.  Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection.

Authors:  Maria R Ambrosio; Giulia De Falco; Alessandro Gozzetti; Bruno J Rocca; Teresa Amato; Vasileios Mourmouras; Sara Gazaneo; Lucia Mundo; Veronica Candi; Pier P Piccaluga; Maria G Cusi; Lorenzo Leoncini; Stefano Lazzi
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

8.  Controversies in neuro-oncology: does valganciclovir have a role in the treatment of high-grade gliomas?

Authors:  Patrick Y Wen
Journal:  Neuro Oncol       Date:  2014-03       Impact factor: 12.300

9.  STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.

Authors:  Nicole A Wilski; Colby Stotesbury; Christina Del Casale; Brian Montoya; Eric Wong; Luis J Sigal; Christopher M Snyder
Journal:  J Immunol       Date:  2020-04-13       Impact factor: 5.422

10.  Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.

Authors:  Nicole A Wilski; Christina Del Casale; Timothy J Purwin; Andrew E Aplin; Christopher M Snyder
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.